CTLPP
CANTALOUPE, INC.
No data for this timeframe.
Vol
SEC Reports5
Exchange OTC·Sector Calculating & Accounting Machines (No Electronic Computers)·Inc. PA·CIK 0000896429
Recent Activity
May 18, 2026
SEC
Cantaloupe, Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective May 18, 2026, citi
15-12G — Impact 8/10
May 13, 2026
SEC
Cantaloupe's shelf registration (File No. 333-255040) became effective on May 12, 2026, allowing the company to sell sec
EFFECT — Impact 4/10
May 8, 2026
SEC
Cantaloupe, Inc. completed its merger with an affiliate of 365 Retail Markets, LLC on May 8, 2026. Shareholders received
8-K — Impact 7/10
Analyst Ratings
0Strong Buy
0Buy
7Hold
1Sell
2Strong Sell
Latest Reports
BEARISH
15-12G
8/10
Cantaloupe, Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective May 18, 2026, citi
May 18, 2026
NEUTRAL
EFFECT
4/10
Cantaloupe's shelf registration (File No. 333-255040) became effective on May 12, 2026, allowing the company to sell sec
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 2 neutral. Avg impact: 6.2/10.
BEARISH
15-12G
8/10
Cantaloupe, Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g), effectiv
May 18, 2026
NEUTRAL
EFFECT
4/10
Cantaloupe's shelf registration (File No. 333-255040) became effective on May 12, 2026, allowing the
May 13, 2026
BEARISH
8-K
7/10
Cantaloupe, Inc. completed its merger with an affiliate of 365 Retail Markets, LLC on May 8, 2026. S
May 8, 2026
BEARISH
25-NSE
8/10
Nasdaq filed a Form 25-NSE to remove Cantaloupe, Inc. common stock from listing and registration, ef
May 8, 2026
NEUTRAL
8-K
4/10
Cantaloupe, Inc. (CTLP) announced termination of the HSR Act waiting period for its merger with 365
May 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 10 analysts — 0 strong buy, 0 buy, 7 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 12.3% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 15.9% | — |
| Current FY 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 13.8% | — |
| Next FY 2027-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 14.4% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Jan 1, 2026 | 3 | 3 | 6 | 0 | 0 | 50% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.